Regarding pricing, from what Absolut told me, it is priced according to the fact that it's not the most technologically advanced tool. For NSG, for sourcing and contracts, I think they pay in the hundreds of thousands a year, maybe two or three hundred thousand pounds, but I'm not certain on that.
Salesforce is priced at a premium, which poses challenges for acquiring it. Small and medium enterprises struggle with the high pricing. I suggest introducing pricing variations based on specific features required by smaller enterprises and adjusting prices to match the economic conditions of different regions.
SAP must reduce the pricing for Ariba. The solution is subscription-based. We pay annually for the tool. The license is expensive. It depends on how many users will be working on the platform.
SAP Ariba Procurement streamlines procurement by integrating supplier management and contracts into a unified platform, enhancing productivity while allowing for seamless configuration and spend analysis.SAP Ariba Procurement centralizes procurement activities, providing dynamic pricing tools such as reverse auctions and PunchOut functionality for simplified shopping. Its spend analytics improve decision-making and supplier visibility. The platform is configurable without third-party...
Regarding pricing, from what Absolut told me, it is priced according to the fact that it's not the most technologically advanced tool. For NSG, for sourcing and contracts, I think they pay in the hundreds of thousands a year, maybe two or three hundred thousand pounds, but I'm not certain on that.
Salesforce is priced at a premium, which poses challenges for acquiring it. Small and medium enterprises struggle with the high pricing. I suggest introducing pricing variations based on specific features required by smaller enterprises and adjusting prices to match the economic conditions of different regions.
There are cheaper options available. The licensing cost depends on the customer.
SAP must reduce the pricing for Ariba. The solution is subscription-based. We pay annually for the tool. The license is expensive. It depends on how many users will be working on the platform.
It is an expensive solution.